Skip to main content
SpringerLink
Log in

Neue Therapien bei NMOSD

„Ein Teil der Patienten könnte die Autoantikörper wieder verlieren“

  • aktuell
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Das Gespräch führte Thomas Müller.

Download references

Author information

Consortia

Springer Medizin

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Springer Medizin. „Ein Teil der Patienten könnte die Autoantikörper wieder verlieren“. InFo Neurologie 21, 6–7 (2019). https://doi.org/10.1007/s15005-019-0248-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-019-0248-2

Search

Navigation